Related Experiment Video
Updated: Jun 12, 2026

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
Published on: March 22, 2012
A fully integrated sample-to-answer molecular diagnostic platform for rapid identification of four major Aspergillus
Eun Hae Oh1, Jinseok Kang1, Dasol Jin1
1iGENETECH R&D Center, iGENETECH Inc., Yongin, Republic of Korea.
Background:
Invasive pulmonary aspergillosis (IPA) is more common among immunocompromised patients. Timely diagnosis is crucial but is challenging because current diagnostic approaches are often limited by low sensitivity, prolonged turnaround times, and technical complexity. Here, we developed a fully automated, real-time PCR-based, sample-to-answer molecular diagnostic platform for the simultaneous identification of four major Aspergillus species (A. fumigatus, A. flavus, A. niger, and A. terreus).
Materials And Methods:
The sample-to-answer workflow was optimized using artificial bronchoalveolar lavage (BAL) samples spiked with Aspergillus species. The platform's performance was evaluated through two primary validation steps: analytical consistency with MALDI-TOF using 21 patient-derived culture isolates, and clinical feasibility validation using 22 clinical BAL specimens from patients categorized as proven (n = 11) or probable (n = 11) IPA.
Results:
The assay demonstrated 95.2% (20/21) overall agreement with MALDI-TOF for culture isolates, achieving 93.3% positive agreement and 100% negative agreement. In the feasibility validation using 22 patient BAL samples including 11 proven and 11 probable IPA cases, the platform detected 10 out of 11 proven IPA samples (90.9%) with 100% species-level consistency with MALDI-TOF results. Notably, this assay could add mycological evidence in 3 of 11 culture-negative probable IPA cases.
Conclusion:
This fully automated, sample-to-answer platform enables rapid and accurate species-level identification of Aspergillus in suspicious IPA. We highlight that this assay offers a powerful molecular tool to overcome the limitations of conventional diagnostic methods in clinical settings.
Insights
A new automated PCR platform rapidly identifies four key Aspergillus species in invasive pulmonary aspergillosis (IPA). This molecular tool overcomes limitations of traditional diagnostics for faster, more accurate patient care.
Area of Science:
- Molecular diagnostics
- Medical mycology
- Infectious disease diagnostics
Background:
- Invasive pulmonary aspergillosis (IPA) disproportionately affects immunocompromised individuals.
- Current diagnostic methods for IPA suffer from low sensitivity, long turnaround times, and technical challenges.
- Accurate and timely diagnosis is critical for effective IPA management.
Purpose of the Study:
- To develop a fully automated, real-time PCR-based, sample-to-answer molecular diagnostic platform.
- To enable simultaneous identification of four major Aspergillus species: A. fumigatus, A. flavus, A. niger, and A. terreus.
- To provide a rapid and accurate diagnostic tool for suspected IPA cases.
Main Methods:
- Optimized a sample-to-answer workflow using artificial bronchoalveolar lavage (BAL) samples spiked with Aspergillus species.
- Evaluated analytical consistency against MALDI-TOF using 21 patient-derived culture isolates.
- Assessed clinical feasibility using 22 clinical BAL specimens from patients with proven or probable IPA.
Main Results:
- Achieved 95.2% overall agreement with MALDI-TOF for culture isolates (93.3% positive, 100% negative agreement).
- In clinical validation, the platform detected 90.9% (10/11) of proven IPA samples with 100% species-level consistency.
- Identified Aspergillus in 3 culture-negative probable IPA cases, adding crucial mycological evidence.
Conclusions:
- The developed automated platform provides rapid and accurate species-level identification of Aspergillus.
- This molecular assay overcomes limitations of conventional diagnostic methods for IPA.
- The platform represents a significant advancement for clinical diagnostics in managing invasive aspergillosis.
Related Concept Videos
Rapid Identification of Pathogens
Automated Microbial Diagnostics
